Biogen Inc.

BIIB.SW plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, BIIB.SW stands at 30.04B. In comparison, BMY.SW has a market cap of 73.96B. Regarding current trading prices, BIIB.SW is priced at $232.00, while BMY.SW trades at $44.50.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

BIIB.SW currently has a P/E ratio of 24.54, whereas BMY.SW's P/E ratio is 16.13. In terms of profitability, BIIB.SW's ROE is +0.08%, compared to BMY.SW's ROE of -0.23%. Regarding short-term risk, BIIB.SW and BMY.SW have similar daily volatility (0.00).

BIIB.SW plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, BIIB.SW stands at 30.04B. In comparison, ROSE.SW has a market cap of 404.49M. Regarding current trading prices, BIIB.SW is priced at $232.00, while ROSE.SW trades at $35.02.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

BIIB.SW currently has a P/E ratio of 24.54, whereas ROSE.SW's P/E ratio is -2.28. In terms of profitability, BIIB.SW's ROE is +0.08%, compared to ROSE.SW's ROE of -0.26%. Regarding short-term risk, BIIB.SW and ROSE.SW have similar daily volatility (0.00).

BIIB.SW plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, BIIB.SW stands at 30.04B. In comparison, DOCM.SW has a market cap of 210.22M. Regarding current trading prices, BIIB.SW is priced at $232.00, while DOCM.SW trades at $17.79.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

BIIB.SW currently has a P/E ratio of 24.54, whereas DOCM.SW's P/E ratio is -2.16. In terms of profitability, BIIB.SW's ROE is +0.08%, compared to DOCM.SW's ROE of -0.26%. Regarding short-term risk, BIIB.SW is less volatile compared to DOCM.SW. This indicates potentially lower risk in terms of short-term price fluctuations for BIIB.SW.